首页> 外文期刊>老年心脏病学杂志(英文版) >Left atrial diameter and atrial fibrillation, but not elevated NT-proBNP,predict the development of pulmonary hypertension in patients with HFpEF
【24h】

Left atrial diameter and atrial fibrillation, but not elevated NT-proBNP,predict the development of pulmonary hypertension in patients with HFpEF

机译:左心房直径和房颤,但NT-proBNP并未升高,可预测HFpEF患者肺动脉高压的发展

获取原文
获取原文并翻译 | 示例
       

摘要

Background The determinants of pulmonary hypertension(PH)due to heart failure with preserved ejection fraction(HFpEF)have been poorly investigated in patients with cardiovascular diseases(CVD).Methods From July 12017 to March 312019,a total of 149 consecutive HFp EF patients hospitalized with CVD were enrolled in this prospective cross-sectional study.A systolic pulmonary artery pressure(PASP)>35 mm Hg estimated by echocardiography was defined as PH-HFp EF.Logistic regression was performed to establish predictors of PH in HFpEF patients.Results Overall,the mean age of participants was 72±11 years,and 74(49.7%)patients were females.A total of 59(39.6%)patients were diagnosed with PH-HFpEF by echocardiography.The left atrial diameter(LAD)was related to the ratio of the transmitral flow velocities/mitral annulus tissue velocities in early diastole(E/E’)and the left ventricular diameter in systole(LVDs).N-Terminal pro B-type natriuretic peptide(NT-proBNP)was not found to be associated with LAD and impaired diastolic or systolic function of the left ventricle.Multivariable logistic regression showed that atrial fibrillation(AF)increased the risk of PH-HFpEF incidence 3.46-fold with a 95%confidence interval(CI)of 1.44–8.32,P=0.005.Meanwhile,LAD≥45 mm resulted in a 3.43-fold increased risk,95%CI:1.51–7.75,P=0.003.However,the significance levels of NT-proBNP,age and LVEF were underpowered in the regression model.Two variables,AF and LAD≥45 mm,predicted the PH-HFpEF incidence(C-statistic=0.773,95%CI:0.695–0.852,P<0.001).Conclusions Two parameters associated with electrical and anatomical remodelling of the left atrium were related to the incidence of PH in HFpEF patients with CVD.

著录项

  • 来源
    《老年心脏病学杂志(英文版)》 |2020年第7期|400-409|共10页
  • 作者单位

    Department of Cardiology Nanjing First Hospital Nanjing Medical University Nanjing China;

    Department of Cardiology Nanjing First Hospital Nanjing Medical University Nanjing China;

    Laboratory of Cardiovascular Diseases Nanjing Heart Centre Nanjing China;

    Department of Cardiology Nanjing First Hospital Nanjing Medical University Nanjing China;

    Laboratory of Cardiovascular Diseases Nanjing Heart Centre Nanjing China;

    Department of Cardiology Nanjing First Hospital Nanjing Medical University Nanjing China;

    Department of Cardiology Nanjing First Hospital Nanjing Medical University Nanjing China;

    Department of Cardiology Nanjing First Hospital Nanjing Medical University Nanjing China;

    Department of Cardiology Nanjing First Hospital Nanjing Medical University Nanjing China;

    Laboratory of Cardiovascular Diseases Nanjing Heart Centre Nanjing China;

    Department of Cardiology Nanjing First Hospital Nanjing Medical University Nanjing China;

    Department of Cardiology Nanjing First Hospital Nanjing Medical University Nanjing China;

    Laboratory of Cardiovascular Diseases Nanjing Heart Centre Nanjing China;

    Department of Cardiology Nanjing First Hospital Nanjing Medical University Nanjing China;

    Laboratory of Cardiovascular Diseases Nanjing Heart Centre Nanjing China;

    Department of Cardiology Guangzhou Red Cross Hospital Jinan University Guangzhou China;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号